矜持
发表于 2025-3-21 16:09:24
书目名称Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0425606<br><br> <br><br>书目名称Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0425606<br><br> <br><br>书目名称Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0425606<br><br> <br><br>书目名称Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0425606<br><br> <br><br>书目名称Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0425606<br><br> <br><br>书目名称Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0425606<br><br> <br><br>书目名称Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0425606<br><br> <br><br>书目名称Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0425606<br><br> <br><br>书目名称Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0425606<br><br> <br><br>书目名称Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0425606<br><br> <br><br>
Conscientious
发表于 2025-3-21 21:07:06
Basil Goldingif ..(.) is the number of (possibly overlapping) occurrences of the word . in the .-ary expansion of ., then the series . can be expressed in terms of the Riemann zeta function or of the Hurwitz zeta function..This allows us to show that . but also to give formulas like .Moreover we give a general expression for the series .For example one has:
jeopardize
发表于 2025-3-22 03:33:26
http://reply.papertrans.cn/43/4257/425606/425606_3.png
腐败
发表于 2025-3-22 06:25:22
http://reply.papertrans.cn/43/4257/425606/425606_4.png
Countermand
发表于 2025-3-22 09:43:20
Seetharama A. Acharya,Marcos Intaglietta,Amy G. Tsai,Fantao Mengis to exhibit links between three topics : automaticity, algebraicity (mod n) and D-finiteness. Diagonals of rational fractions seem to be at the heart of the problem. In the last part, we show they appear as (regular) solutions near singularity of Picard-Fuchs differential equations.
填满
发表于 2025-3-22 13:06:51
http://reply.papertrans.cn/43/4257/425606/425606_6.png
inveigh
发表于 2025-3-22 19:58:49
Xianren Wu,Nancy T.Ho,Tong-Jian Shen,Vincent Vagni,David K. Shellington,Keri Janesko-Feldman,Tsueyif ..(.) is the number of (possibly overlapping) occurrences of the word . in the .-ary expansion of ., then the series . can be expressed in terms of the Riemann zeta function or of the Hurwitz zeta function..This allows us to show that . but also to give formulas like .Moreover we give a general expression for the series .For example one has:
捐助
发表于 2025-3-22 22:50:11
Shinichi Kaneda,Takanobu Ishizuka,Hiroshi Goto,Hiroaki Kasukawaif ..(.) is the number of (possibly overlapping) occurrences of the word . in the .-ary expansion of ., then the series . can be expressed in terms of the Riemann zeta function or of the Hurwitz zeta function..This allows us to show that . but also to give formulas like .Moreover we give a general expression for the series .For example one has:
inhumane
发表于 2025-3-23 02:25:02
John P. Harrington,Hanna Wollockois to exhibit links between three topics : automaticity, algebraicity (mod n) and D-finiteness. Diagonals of rational fractions seem to be at the heart of the problem. In the last part, we show they appear as (regular) solutions near singularity of Picard-Fuchs differential equations.
打包
发表于 2025-3-23 07:23:34
From Hemoglobin Based Oxygen Carrier to Oxygen Therapeutics, Blood Substitutes, Nanomedicine and Art.) and stroma-free Hb as Hb based oxygen carrier (Rabiner et al. .) resulted in nephrotoxicity and cardiovascular adverse effects (Savitsky et al. .). Thus, nanobiotechnological modification is needed before it can be used (Chang .)